Cloud AI Today - Novo Nordisk Partners With AWS For AI-Driven Drug Discovery

Microsoft Corporation

Microsoft Corporation

MSFT

0.00

Novo Nordisk has entered a strategic partnership with Amazon Web Services (AWS) to enhance drug discovery using artificial intelligence and cloud technologies. This collaboration includes establishing a co-innovation hub in London, which brings together AWS engineers, AI specialists, and Novo Nordisk's research and development teams to streamline the process of bringing new medicines to market. As part of this agreement, AWS becomes Novo Nordisk's preferred cloud provider and strategic AI partner, leveraging AWS's AI technologies to compress timelines from drug target identification to clinical trials. The partnership aims to modernize Novo Nordisk’s operations and harness AI-driven innovations across its efforts in treating chronic diseases.

In other market news, Datadog (NasdaqGS:DDOG) was a standout up 11.5% and closing at $260.78. In the meantime, Lumentum Holdings (NasdaqGS:LITE) lagged, down 8.6% to finish the session at $813.51.

Best Cloud AI Stocks

  • ServiceNow (NYSE:NOW) ended the day at $127.44 up 2%.
  • Microsoft (NasdaqGS:MSFT) finished trading at $506.06 up 1.2%. Blackbaud Inc. recently announced a new Copilot-enabled agent that integrates its Raiser's Edge NXT with Microsoft 365 applications, enhancing fundraising insights and decision-making, 1 day ago.
  • Alphabet (NasdaqGS:GOOGL) ended the day at $357.52 up 0.9%.

Make It Happen

  • Click this link to deep-dive into the 155 companies within our Cloud AI Stocks screener including DigitalOcean Holdings, Quanta Computer and CGI.
  • Ready For A Different Approach? Uncover 20 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Sources:

    This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.